We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$86.7B
AUM Growth
-$17.2B
Cap. Flow
-$19.4B
Cap. Flow %
-22.34%
Top 10 Hldgs %
24.65%
Holding
7,637
New
330
Increased
2,121
Reduced
4,377
Closed
488

Sector Composition

Rank Sector Weight
1 Healthcare 7.58%
2 Technology 5.48%
3 Financials 4.9%
4 Energy 3.61%
5 Consumer Discretionary 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVE icon
5601
Universal Insurance Holdings
UVE
$1.23B
$23K ﹤0.01%
935
-1,088
-54% -$25.6K
BKCC
5602
DELISTED
BlackRock Capital Investment Corporation
BKCC
$23K ﹤0.01%
2,601
HNGR
5603
DELISTED
Hanger Inc.
HNGR
$23K ﹤0.01%
1,061
-3,508
-77% -$82.3K
RAVN
5604
DELISTED
Raven Industries Inc
RAVN
$23K ﹤0.01%
1,096
-2,802
-72% -$60.6K
FPRX
5605
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$23K ﹤0.01%
1,002
+20
+2% +$505
CZZ
5606
DELISTED
Cosan Limited
CZZ
$23K ﹤0.01%
3,849
-937
-20% -$6.68K
CZZ
5607
PUT
DELISTED
Cosan Limited
CZZ
$23K ﹤0.01%
3,800
+1,800
+90% +$12.8K
AXE
5608
CALL
DELISTED
Anixter International Inc
AXE
$23K ﹤0.01%
300
-700
-70% -$54.6K
STBZ
5609
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$23K ﹤0.01%
1,054
-1,555
-60% -$30.8K
RSO
5610
DELISTED
Resource Capital Corp.
RSO
$23K ﹤0.01%
1,376
-464
-25% -$8.91K
NEWP
5611
DELISTED
NEWPORT CORP
NEWP
$23K ﹤0.01%
1,196
-1,073
-47% -$20.8K
HMIN
5612
PUT
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
$23K ﹤0.01%
1,000
+700
+233% +$18.1K
AMKR icon
5613
PUT
Amkor Technology
AMKR
$13.7B
$22K ﹤0.01%
2,800
-3,300
-54% -$26.8K
ARAY icon
5614
PUT
Accuray
ARAY
$34M
$22K ﹤0.01%
+2,400
New +$19.1K
CVGW
5615
DELISTED
Calavo Growers
CVGW
$22K ﹤0.01%
435
-734
-63% -$32.9K
ENTA icon
5616
Enanta Pharmaceuticals
ENTA
$400M
$22K ﹤0.01%
739
-93
-11% -$3.62K
LPSN icon
5617
CALL
LivePerson
LPSN
$32.3M
$22K ﹤0.01%
147
-420
-74% -$70.9K
LRMR icon
5618
Larimar Therapeutics
LRMR
$432M
$22K ﹤0.01%
49
+2
+4% +$949
MITT
5619
TPG Mortgage Investment Trust
MITT
$225M
$22K ﹤0.01%
399
-140
-26% -$7.83K
TVTX icon
5620
Travere Therapeutics
TVTX
$5.78B
$22K ﹤0.01%
972
-296
-23% -$4.51K
TXRH icon
5621
PUT
Texas Roadhouse
TXRH
$13.7B
$22K ﹤0.01%
+600
New +$21.3K
UTI icon
5622
Universal Technical Institute
UTI
$1.59B
$22K ﹤0.01%
2,496
-539
-18% -$5.01K
HSTO
5623
DELISTED
Histogen Inc. Common Stock
HSTO
$22K ﹤0.01%
+16
New +$20.3K
RPXC
5624
DELISTED
RPX Corporation
RPXC
$22K ﹤0.01%
1,593
-1,428
-47% -$19.6K
RATE
5625
DELISTED
Bankrate Inc
RATE
$22K ﹤0.01%
2,019
-17,700
-90% -$220K

Similar funds

Barclays's Q1 2015 Portfolio in Review

As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.

Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.

  • Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
  • Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
  • Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
  • Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
  • Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
  • Barclays opened 330 new positions and closed 488 in Q1 2015.
  • Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.